Insider: Sony Has Begun Working on the Return of Tobey Maguire and Andrew Garfield’s Spider-Men

Movie insider Daniel Richtman reports that Sony is planning the return of Tobey Maguire and Andrew Garfield’s Spider-Men. According to the insider, Sony wants to bring both Spider-Men back to the big screen. These characters will become key heroes in their own universe, separate from the MCU. It’s unclear if this universe will be connected…

Read More

In honor of the anniversary of Diablo IV, players will receive free items, and the game will host the “Goblin March” event

Blizzard has announced that in honor of the upcoming first anniversary of Diablo IV, which will take place on June 6, a special celebratory event called the “Goblin March” will be held in the game. The festive event will begin on June 6 and will offer players the following exciting activities: – Until June 13,…

Read More

Microsoft Releases Chatbot for US Intelligence Agencies

Microsoft has unveiled a generative AI model based on GPT-4, specifically developed for US intelligence agencies, which operates without internet connection. This marks Microsoft’s first deployment of a large language model in a secure environment. It allows intelligence services to analyze top-secret information without the risk of internet leaks and securely communicate with a chatbot…

Read More

Japanese Gamers Outraged Over Announcement of Assassin’s Creed: Shadows

The cinematic trailer for the new Assassin’s Creed turned out to be impressive, but it evoked mixed feelings among many players. The series is finally reaching the most desired setting among fans – feudal Japan. However, the realization of the game seemed very controversial to most users. Players are debating Assassin’s Creed: Shadows for various…

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More